Huan Geng

774 total citations · 1 hit paper
21 papers, 602 citations indexed

About

Huan Geng is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Huan Geng has authored 21 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Biomedical Engineering and 6 papers in Oncology. Recurrent topics in Huan Geng's work include Bone health and treatments (6 papers), Graphene and Nanomaterials Applications (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Huan Geng is often cited by papers focused on Bone health and treatments (6 papers), Graphene and Nanomaterials Applications (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Huan Geng collaborates with scholars based in China, Austria and United States. Huan Geng's co-authors include Rui Shi, Liqun Zhang, Liang Liu, Wanying Zhang, Tanghao Liu, Cheng Chen, Jun Zhao, Xiaohua Hu, Chengai Wu and Min Gong and has published in prestigious journals such as Chemical Engineering Journal, Journal of Colloid and Interface Science and Small.

In The Last Decade

Huan Geng

21 papers receiving 596 citations

Hit Papers

The physiological metabolite α-ketoglutarate ameliorates ... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huan Geng China 13 212 193 174 74 70 21 602
Daidi Fan China 12 322 1.5× 204 1.1× 165 0.9× 52 0.7× 76 1.1× 25 769
Xu-Qi Kang China 18 304 1.4× 271 1.4× 336 1.9× 33 0.4× 77 1.1× 22 1.0k
Wenjuan Li China 16 159 0.8× 124 0.6× 81 0.5× 34 0.5× 33 0.5× 43 548
Yunpeng Zhao China 17 204 1.0× 72 0.4× 127 0.7× 101 1.4× 92 1.3× 32 765
Xinliang Chen China 15 137 0.6× 179 0.9× 169 1.0× 114 1.5× 268 3.8× 43 812
Wanli Li China 11 144 0.7× 51 0.3× 149 0.9× 115 1.6× 81 1.2× 34 606
Ayşegül Doğan Türkiye 19 276 1.3× 171 0.9× 210 1.2× 37 0.5× 225 3.2× 64 1.0k
Shifen Li China 13 102 0.5× 150 0.8× 175 1.0× 42 0.6× 88 1.3× 36 583
Si Wang China 13 220 1.0× 117 0.6× 308 1.8× 24 0.3× 90 1.3× 27 695
Govinda Bhattarai South Korea 19 439 2.1× 67 0.3× 185 1.1× 84 1.1× 82 1.2× 48 1.1k

Countries citing papers authored by Huan Geng

Since Specialization
Citations

This map shows the geographic impact of Huan Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan Geng more than expected).

Fields of papers citing papers by Huan Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan Geng. The network helps show where Huan Geng may publish in the future.

Co-authorship network of co-authors of Huan Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Huan Geng. A scholar is included among the top collaborators of Huan Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan Geng. Huan Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Mengxue, Ying Wang, Huan Geng, et al.. (2025). EGCG and DOX dual-drug-loaded enzyme-responsive nanovesicles boost mitochondrial-mediated ICD for improved immunotherapy. Frontiers in Pharmacology. 16. 1624109–1624109. 2 indexed citations
3.
Liu, Xiao, et al.. (2024). Erythropoietin regulates osteoclast formation via up-regulating PPARγ expression. Molecular Medicine. 30(1). 151–151. 3 indexed citations
4.
Zhou, Mengxue, Chuang Zhou, Huan Geng, et al.. (2024). EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer. Small. 21(14). e2406245–e2406245. 10 indexed citations
5.
Liu, Liang, Wanying Zhang, Tanghao Liu, et al.. (2023). The physiological metabolite α-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress. Redox Biology. 62. 102663–102663. 136 indexed citations breakdown →
6.
Yang, Xiaofang, et al.. (2022). Rhein Protects Against Severe Acute Pancreatitis In vitro and In vivo by Regulating the JAK2/STAT3 Pathway. Frontiers in Pharmacology. 13. 778221–778221. 12 indexed citations
8.
Hu, Dongcai, et al.. (2022). EGCG regulated osteolytic microenvironment to enhance the antitumor effect of DOX on orthotopic osteosarcoma. Journal of Functional Foods. 94. 105118–105118. 1 indexed citations
9.
Zhang, Di, et al.. (2021). Salidroside protects endothelial cells against LPS-induced inflammatory injury by inhibiting NLRP3 and enhancing autophagy. BMC Complementary Medicine and Therapies. 21(1). 146–146. 24 indexed citations
10.
Liu, Liang, et al.. (2021). Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS‐PI3K/AKT Signaling and Attenuated Osteolysis. Oxidative Medicine and Cellular Longevity. 2021(1). 6661534–6661534. 26 indexed citations
11.
Geng, Huan, et al.. (2021). The comparison analysis of polyphyllin I and its analogues induced apoptosis of colon and lung cancer cells via mitochondrial dysfunction. Basic & Clinical Pharmacology & Toxicology. 129(1). 15–25. 14 indexed citations
12.
Chen, Kui, Huan Geng, Wei Liang, et al.. (2020). Modulated podosome patterning in osteoclasts by fullerenol nanoparticles disturbs the bone resorption for osteoporosis treatment. Nanoscale. 12(17). 9359–9365. 16 indexed citations
13.
Han, Bing, Huan Geng, Liang Liu, Zhixin Wu, & Yi‐Zhong Wang. (2020). GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo. Biomedicine & Pharmacotherapy. 128. 110305–110305. 27 indexed citations
14.
Geng, Huan, Mengxue Zhou, Bin Li, et al.. (2020). Metal-drug nanoparticles-mediated osteolytic microenvironment regulation for enhanced radiotherapy of orthotopic osteosarcoma. Chemical Engineering Journal. 417. 128103–128103. 23 indexed citations
15.
Gu, Weihong, Kui Chen, Xiaoyi Zhao, et al.. (2018). Highly Dispersed Fullerenols Hamper Osteoclast Ruffled Border Formation by Perturbing Ca2+ Bundles. Small. 14(48). e1802549–e1802549. 11 indexed citations
16.
Zeng, Li, Huan Geng, Weihong Gu, et al.. (2018). Au Nanoparticles Attenuate RANKL-Induced Osteoclastogenesis by Suppressing Pre-Osteoclast Fusion. Journal of Nanoscience and Nanotechnology. 19(4). 2166–2173. 13 indexed citations
17.
Shi, Rui, Huan Geng, Min Gong, et al.. (2017). Long-acting and broad-spectrum antimicrobial electrospun poly (ε-caprolactone)/gelatin micro/nanofibers for wound dressing. Journal of Colloid and Interface Science. 509. 275–284. 107 indexed citations
18.
Geng, Huan, Yanan Chang, Xue Bai, et al.. (2017). Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation. Nanoscale. 9(34). 12516–12523. 43 indexed citations
19.
Li, Juan, Wenjiang Yang, Rongli Cui, et al.. (2016). Metabolizerin vivoof fullerenes and metallofullerenes by positron emission tomography. Nanotechnology. 27(15). 155101–155101. 12 indexed citations
20.
He, Min, Jiajia Xue, Huan Geng, et al.. (2015). Fibrous guided tissue regeneration membrane loaded with anti-inflammatory agent prepared by coaxial electrospinning for the purpose of controlled release. Applied Surface Science. 335. 121–129. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026